Who is sponsoring NCT03513315?

NCT03513315 is sponsored by Johns Hopkins University.

What drugs are being tested in NCT03513315?

Interventions in NCT03513315: Implementation of Community-based Home Heat Bundle, Regular Community Healthcare provision.

What condition does NCT03513315 study?

NCT03513315 studies Heat Illness, Heat Stroke, Heat Exhaustion, Heat Exposure, Heat Syncope, Sequela, Heat Collapse, Heat, Heat Stroke and Sunstroke.

Is NCT03513315 still recruiting?

NCT03513315 is currently completed. Last updated 9 January 2019.

Last reviewed 2019-01-09 · How we verify

NCT03513315: HEAT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Heat Emergency Awareness and Treatment (HEAT)

Completed NA Last updated 9 January 2019

What this trial tests

NA trial testing Implementation of Community-based Home Heat Bundle in Heat Illness in 16,973 participants. Completed in 30 October 2018.

Timeline

30 November 2016

Primary endpoint
30 October 2018

30 October 2018

Quick facts

Lead sponsor	Johns Hopkins University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	16,973
Start date	30 November 2016
Primary completion	30 October 2018
Estimated completion	30 October 2018
Sites	2 locations across Pakistan

Drugs / interventions tested

Implementation of Community-based Home Heat Bundle
Regular Community Healthcare provision

Conditions studied

Heat Illness — all drugs for Heat Illness →
Heat Stroke — all drugs for Heat Stroke →
Heat Exhaustion — all drugs for Heat Exhaustion →
Heat Exposure — all drugs for Heat Exposure →

Sponsor

Johns Hopkins University

Who can join

Eligibility, any sex, with Heat Illness or Heat Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators propose an intervention trial of a comprehensive education and treatment bundle designed to reduce morbidity and mortality associated with heat-related illness for low resource settings. Two set of interventions will be developed each for emergency department and for community/home. These interventions will be developed by an internal expert group and will be customized and implemented at the home and emergency department (ED) levels, will include evidence-based educational training guidelines for ED health providers as well as educational messages targeting home and community in Karachi, Pakistan.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Impact of community education on heat-related health outcomes and heat literacy among low-income communities in Karachi, Pakistan: a randomised controlled trial.
Razzak JA, Agrawal P, Chand Z, Quraishy S, et al · · 2022 · cited 17× · PMID 35101860 · DOI 10.1136/bmjgh-2021-006845
Heat Emergencies: Perceptions and Practices of Community Members and Emergency Department Healthcare Providers in Karachi, Pakistan: A Qualitative Study.
Khan UR, Ahmed N, Naeem R, Khudadad U, et al · · 2021 · cited 7× · PMID 33946755 · DOI 10.3390/ijerph18094736

Verify or expand the search:

Other recruiting trials for Heat Illness

Currently open trials in the same condition.

NCT07500545 — Community Health Adaptation & Resilience Mobilization (CHARM) HeatWise · NA · recruiting
NCT05717777 — Treatment of Exertional Heatstroke witH icE wAter Soaked Towels · active not recruiting

Other Johns Hopkins University trials

Trials by the same sponsor.

NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03513315 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
Last refreshed: 9 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03513315.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing